Marchex(MCHX)

Search documents
Marchex(MCHX) - 2021 Q3 - Quarterly Report
2021-11-10 21:08
Revenue and Financial Performance - The allowance for advertiser credits was $227,000 as of December 31, 2020, and decreased to $219,000 by September 30, 2021[38]. - The deferred revenue balance was $1.4 million as of December 31, 2020, and decreased to $1.3 million by September 30, 2021[38]. - Revenue recognized from contract liabilities for the three months ended September 30, 2021, was $176,000, compared to $166,000 for the same period in 2020[38]. - For the nine months ended September 30, 2021, revenue recognized from contract liabilities was $1.3 million, up from $974,000 in 2020[38]. - The majority of the Company's revenue is derived from the United States, accounting for 99% of total revenue for the three months ended September 30, 2021[44]. - There were no customers representing more than 10% of consolidated revenue for the three and nine months ended September 30, 2021[45]. - One customer represented 19% of consolidated accounts receivable as of September 30, 2021[46]. Cash and Expenses - As of September 30, 2021, the total cash and cash equivalents decreased to $27,781,000 from $33,851,000 as of December 31, 2020, representing a decline of approximately 18%[48]. - Stock-based compensation expense for the nine months ended September 30, 2021, was $2,007,000, down from $2,624,000 for the same period in 2020, indicating a reduction of about 23%[51]. - The total stock-based compensation for the three months ended September 30, 2021, was $608,000, down from $817,000 for the same period in 2020, reflecting a decrease of approximately 25%[51]. - The depreciation and amortization expense related to property and equipment for the nine months ended September 30, 2021 was approximately $965 thousand, down from $1.2 million in the same period of 2020[60]. - The company recognized an operating lease cost of $1,381 thousand for the nine months ended September 30, 2021[66]. Net Loss and Earnings Per Share - The basic net loss per share applicable to common stockholders for the nine months ended September 30, 2021, was $(0.70) compared to $(0.70) for the same period in 2020, showing no change year-over-year[57]. - The net loss from continuing operations for Class A common stockholders for the nine months ended September 30, 2021, was $(250,000), compared to $(3,571,000) for the same period in 2020[57]. - For the nine months ended September 30, 2021, the diluted net loss per share applicable to common stockholders was $(0.70) for Class A and Class B shares, compared to $(0.70) for the same period in 2020[58]. - The net loss from continuing operations for the nine months ended September 30, 2021 was $(2,355) thousand, compared to $(36,329) thousand for the same period in 2020[58]. Assets and Liabilities - The Company operated in a single segment focused on core analytics and solutions services for the nine months ended September 30, 2021[42]. - No significant long-lived assets were held by entities outside of the United States as of September 30, 2021[43]. - The balance of stock options at September 30, 2021, was 3,532,000, slightly up from 3,460,000 at December 31, 2020[53]. - The company had gross future operating lease payments of $3,890 thousand as of September 30, 2021[67]. - The total long-term operating lease liabilities as of September 30, 2021 amounted to $1,926 thousand[67]. - The weighted-average remaining lease term for operating leases was 2.1 years as of September 30, 2021[66]. Intangible Assets and Impairments - As of September 30, 2021, total identifiable intangible assets from acquisitions amounted to $5.488 million, down from $9.196 million as of December 31, 2020[78]. - The Company recorded a pre-tax non-cash impairment of $5.0 million in Q1 2020 related to customer relationships, technologies, non-compete agreements, and tradenames[77]. - The balance of goodwill remained unchanged at $17.6 million as of September 30, 2021[79]. - The Company recorded a 100% valuation allowance against deferred tax assets as of September 30, 2021, indicating uncertainty in realizing these assets[73]. Other Financial Activities - The Company secured $5.3 million in promissory notes under the CARES Act, with a remaining balance of $5.1 million as of December 31, 2020, and recognized a gain on extinguishment of $5.2 million in Q3 2021[83]. - The Company received approximately $135,000 and $434,000 in foreign wage subsidy funding during the three and nine months ended September 30, 2021, respectively[84]. - The Company sold certain assets for approximately $2.3 million in October 2020, which were classified as discontinued operations[86]. - The Company entered into an administrative support services agreement with the related party purchaser, generating support services fees of $2.2 million and $5.1 million for the three and nine months ended September 30, 2021, respectively[87]. - The Company has no known legal proceedings that are expected to have a material adverse effect on its financial condition[71]. - The Company performed annual impairment testing for goodwill on November 30, with no additional impairment loss determined after the initial $14.7 million loss in Q1 2020[80].
Marchex(MCHX) - 2021 Q2 - Quarterly Report
2021-08-12 20:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR Delaware 35-2194038 (State or other jurisdiction of ...
Marchex(MCHX) - 2021 Q2 - Earnings Call Transcript
2021-08-08 16:23
Marchex, Inc. (NASDAQ:MCHX) Q2 2021 Earnings Conference Call August 4, 2021 5:00 PM ET Company Participants Trevor Caldwell ??? Senior Vice President of Investor Relations and Strategic Initiatives Michael Arends ??? Chief Executive Officer Russell Horowitz ??? Executive Chairman Leila Kirske ??? Chief Financial Officer Conference Call Participants Austin Vetterick ??? ROTH Capital Partners Operator Good afternoon. Thank you for attending the Marchex???s Second Quarter 2021 Earnings Call. [Operator Instruct ...
Marchex(MCHX) - 2021 Q1 - Earnings Call Transcript
2021-05-14 03:04
Marchex, Inc. (NASDAQ:MCHX) Q1 2021 Earnings Conference Call May 13, 2021 5:00 PM ET Company Participants Trevor Caldwell - SVP IR Michael Arends - Co-CEO Russell Horowitz - Co-CEO Leila Kirske - CFO Conference Call Participants Operator Good afternoon. My name is Celine. And I will be your conference operator today. At this time, I would like to welcome everyone to the Marchex First Quarter 2021 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker ...
Marchex(MCHX) - 2021 Q1 - Quarterly Report
2021-05-13 20:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR WASHINGTON, D.C. 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 10-Q For the transition period from to . (Mark One) Commission File Number 000-50658 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...
Marchex(MCHX) - 2020 Q4 - Annual Report
2021-03-31 19:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-50658 Marchex, Inc. | (Exact name of Registrant as specified in its Charter) | | --- | | Delaware 35-2194038 | | | --- | --- | | (Sta ...
Marchex(MCHX) - 2020 Q4 - Earnings Call Transcript
2021-03-03 01:58
Marchex, Inc. (NASDAQ:MCHX) Q4 2020 Earnings Conference Call March 2, 2021 5:00 PM ET Company Participants Trevor Caldwell - Senior Vice President-Strategic Initiatives & Investor Relations Michael Arends - Co-Chief Executive Officer & Chief Financial Officer Russell Horowitz - Executive Chairman & Co-Chief Executive Officer Conference Call Participants Mike Latimore - Northland Securities Operator Ladies and gentlemen, thank you for standing by and welcome to the Marchex Fourth Quarter 2020 Earnings Call. ...
Marchex(MCHX) - 2020 Q3 - Quarterly Report
2020-11-05 21:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdictio ...
Marchex(MCHX) - 2020 Q3 - Earnings Call Transcript
2020-11-05 01:28
Marchex, Inc. (NASDAQ:MCHX) Q3 2020 Earnings Conference Call November 4, 2020 5:00 PM ET Company Participants Trevor Caldwell - VP, IR and Strategic Initiatives Michael Arends - Co-CEO and CFO Russell Horowitz - Executive Chairman Conference Call Participants Darren Aftahi - ROTH Capital Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to Marchex Third Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there wil ...
Marchex(MCHX) - 2020 Q2 - Quarterly Report
2020-08-10 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 000-50658 Marchex, Inc. (Exact name of Registrant as specified in its charter) Delaware 35-2194038 (State or other jurisdiction of ...